Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer

Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was approved in Europe for the radioiodine ablation of low-risk differentiated thyroid cancer (DTC) during thyroid hormone therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Biondi, Bernadette, Pulcrano, Melania, Pagano, Loredana, Lombardi, Gaetano
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726080/
https://www.ncbi.nlm.nih.gov/pubmed/19707391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726080/
https://www.ncbi.nlm.nih.gov/pubmed/19707391

Ejemplares similares